Italy: public pharmaceutical expenditure in 2016, by ATC
This statistic illustrates the levels of public pharmaceutical expenditure in Italy in 2016, by ATC. According to data, most of the spending was, addressed to antineoplastic and immunomodulatory drugs and to antimicrobial for systemic use. The therapeutic class with the lowest level of expenditure was instead, the one including anti-parasitic products, insecticides and repellents.